Keyword Analysis & Research: cellectis
Keyword Research: People who searched cellectis also searched
Search Results related to cellectis on Search Engine
-
Home | Cellectis
https://www.cellectis.com/
WebBest-In-Class Gene Editing. Cellectis leverages its leadership in gene editing through its flagship technology, TALEN ®, which allows the company to create CAR T therapies to bring new hope to cancer patients through broadly available, off-the-shelf therapies.
DA: 51 PA: 49 MOZ Rank: 58
-
About | Cellectis
https://www.cellectis.com/en/about
WebCellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. Our Mission Cellectis has 24 years of expertise in gene editing based on its flagship TALEN® technology and …
DA: 97 PA: 17 MOZ Rank: 93
-
Cellectis - Wikipedia
https://en.wikipedia.org/wiki/Cellectis
WebCellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
DA: 72 PA: 80 MOZ Rank: 80
-
Our Mission | Cellectis
https://www.cellectis.com/en/our-story/
WebOur Mission. Cellectis has 24 years of expertise in gene editing based on its flagship TALEN ® technology and pioneering electroporation system PulseAgile. Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to ...
DA: 90 PA: 87 MOZ Rank: 55
-
Products | Cellectis
https://www.cellectis.com/en/products
WebCellectis is pioneering robust first-in-class allogeneic CAR T-cell programs that address multiple unmet cancer needs. These programs were designed with simplicity, availability and cost-effectiveness for patients.
DA: 77 PA: 11 MOZ Rank: 61
-
Careers | Cellectis
https://www.cellectis.com/en/careers/
WebOur business draws on a wide range of job skills and includes people with different academic backgrounds, career histories, and experience. At Cellectis, every position helps our company excel. Join our team!
DA: 14 PA: 11 MOZ Rank: 27
-
Investors | Cellectis
https://www.cellectis.com/en/investors/
Web13,637. High. 2.3600. Capitalization. 168.257M. Last Update: about 24 minutes ago. See stock information. Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer.
DA: 65 PA: 21 MOZ Rank: 57
-
Press | Cellectis
https://www.cellectis.com/en/press
WebCellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca. Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer.
DA: 78 PA: 94 MOZ Rank: 14
-
Cellectis to Receive up to $245M in Collaboration with AstraZeneca
https://www.insideprecisionmedicine.com/topics/precision-medicine/cellectis-to-receive-up-to-245m-in-collaboration-with-astrazeneca/
WebNovember 1, 2023. Gene editing company Cellectis stands to collect as much as $245 million in cash and equity investment in the company via a collaboration with AstraZeneca as the pharma giant continues its push into the cell and gene therapy space. Under the terms of the agreement AstraZeneca will gain access to the proprietary gene editing ...
DA: 15 PA: 66 MOZ Rank: 98
-
Cellectis | LinkedIn
https://www.linkedin.com/company/cellectis
WebCellectis | 39,783 followers on LinkedIn. Cellectis is developing life-changing product candidates to target and eradicate cancer cells. | Cellectis is developing the first of its kind allogeneic ...
DA: 48 PA: 34 MOZ Rank: 70
